Browse > Article
http://dx.doi.org/10.22246/jikm.2019.40.5.999

A Case Report of Korean Medicine Treatment for Acute Cerebral Infarction with Cerebral Hemorrhage  

Jeon, Sang-woo (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University)
Lee, Gi-hyang (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University)
Kang, Sei-young (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University)
Publication Information
The Journal of Internal Korean Medicine / v.40, no.5, 2019 , pp. 999-1006 More about this Journal
Abstract
Objectives: The purpose of this study was to report the improvement of symptoms by Korean medicine in acute hemorrhagic infarction. Method: The patient was diagnosed with a cerebral infarction of the right temporal lobe accompanied by cerebral hemorrhage of the left basal ganglia. He did not receive intravenous thrombolytic treatment. Sunghyangjungi-san-gamibang was initially administered, and Gami-daebo-tang was administered during the recovery phase, together with Uhwangchungsim-won, Simjeok-hwan, and acupuncture. The prognostic observation was conducted using the manual muscle test (MMT), the Korean version of the modified Bathel index (K-MBI), and subjective assessment. Results: After Korean medicine treatment, the K-MBI score was improved from 52 to 93. The MMT score and subjective assessment also showed improvement. Conclusions: For patients who cannot be treated with intravenous thrombolytic treatment, Korean medicine treatment is effective during the early and recovery stages of stroke.
Keywords
hemorrhagic infarction; manual muscle test (MMT); modified Bathel index (MBI); Korean medicine;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Rha JH, Saver JL. The Impact of Recanalization on Ischemic Stroke Outcome A Meta-Analysis. Stroke 2007;38(3):967-73.   DOI
2 Kim HJ, Jung SM, Kim SJ, Kim BU, Jun SY, Hong S. A clinical report on two cases of Hemorrhagic infarction patients. J Int Korean Med 2004;25(4):177-85.
3 Yang JY, Kim MS, Jeong TS, Bang CH, Mo MJ, Kwon DI, et al. A Case Report of Traditional Korean Medicine for Left Anterior Cerebral Artery (ACA) Infarction and Hemorrhagic Transformation with Hemiplegia and Urinary Disturbance. J Int Korean Med 2016;37(5):786-95.   DOI
4 Korea Statistical Infomation System (KOSIS), News release, Cause of death statistics 2017 [Internet].[cited 2018 September 19]
5 Ministry of Health and Welfare. "Primary Cardiocerebrovascular disease Comprehensive Management Plan(2018-2022)." GOV.KR. September 07 2018. https://www.gov.kr/portal/gvrnPublish/view/_GV_000000005049?srchOrder=DATE&pageIndex=1&policyType=G00303&blgCd=&slgCd=&srchBlgCd=&srchSlgCd=&srchOriginOrg=&srchPeriodOption=1years&srchStDtFmt=2017.10.10.&srchEdDtFmt=2018.10.10.&se archField=3&srchTxt=&srchTxt2=.
6 Clinical Research Center For Stroke. Clinical practice guidelines for stroke. Seoul: Clinical Research Center For Stroke; 2013, p. 4.
7 Kwon JH, Rha JH. Recent advances in thrombolysis of acute ischemic stroke. J Korean Med Assoc 2013;56(5):402-9.   DOI
8 Young HY, Park BK, Shin HS, Kang YK, Pyun SB, Paik NJ, et al. Development of the Korean Version of Modified Barthel Index (K-MBI): Multi-center Study for Subjects. Ann Rehabil Med 2007;31(3):283-97.
9 Fugate JE, Rabinstein AA. Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke. Neurohospitalist 2015;5(3):110-21.   DOI
10 Kim JS, Lee KB, Song IU. Effects of the Customized Self-Exercise Program on Muscle Strength and Walking Function in Stroke Patients. Phys Ther Korea 2019;26(1):37-50.   DOI
11 Korea Stroke Society. Textbook of STROKE. Seoul: PanMun Education; 2015, p. 67, 69-70, 529.
12 Hornig CR, Bauer T, Simon C, Trittmacher S, Dorndorf W. Hemorrhagic Transformation in Cardioembolic Cerebral Infarction. Stroke 1993;24(3):465-8.   DOI
13 The education committee of Korean medicine college for cardiology and neurology. The cardiology and neurology in Korean medicine. Seoul: Koonja publishing company; 2011, p. 404-10.
14 Shin JY. Bangyakhappyeon commentary. Seoul: Seongbosa; 2005, p. 22, 98-9.
15 Jeong B, Lee JS. Effects of Sunghyangjungki-san (Xingxiangzhengqi-san) on Bax and Bcl-2 Expressions in the MCAO Rats. J Int Korean Med 2008;18(2):33-43.
16 Lee DS, Nam HI, Jeong JJ, Kim BW, Sun SH, Baik TH. An Ultrasound-case Report on Efficacy of Korean-Western Intergrated Medical Treatment in Reducing Thickness of Carotid Artery Atherosclerosis. J Int Korean Med 2014;spr:259-65.
17 Lansberg MG, Bluhmki E, Thijs VN. Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic Stroke. Stroke 2009;40(7):2438-41.   DOI
18 Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States : A Doubling of Treatment Rates Over the Course of 5 Years. Stroke 2011;42(7):1952-5.   DOI